CausalSentinel

Protein Dossier — EPHA1 (Ephrin type-A receptor 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypertrophic cardiomyopathy (hcm or hocm) 0.691 0.193 3.39e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: B37 Candidiasis 0.503 0.156 0.00127 Wald ratio 1 cis NA
Eczema -0.105 0.0374 0.00482 Wald ratio 1 cis NA
Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip] 0.104 0.0395 0.0085 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hyperthyroidism or thyrotoxicosis 0.134 0.0536 0.0124 Wald ratio 1 cis NA
Bipolar disorder -0.123 0.0506 0.015 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoporosis 0.0926 0.0385 0.0162 Wald ratio 1 cis NA
Sleep duration 0.00959 0.0041 0.0195 Wald ratio 1 cis NA
Non-cancer illness code self-reported: psoriasis 0.101 0.0449 0.025 Wald ratio 1 cis NA
Eye problems or disorders: Diabetes related eye disease -0.17 0.0797 0.0329 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0298 0.014 0.0332 Wald ratio 1 cis NA
Non-cancer illness code self-reported: gout 0.0841 0.0406 0.0383 Wald ratio 1 cis NA
…and 95 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3431_54_2 EphA1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

102 association rows across 63 traits (84 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Ephrin type-A receptor 1 levels 4e-778 rs4725617 8 GCST90247471 no MR -> candidate analysis
BTN2A1/EPHA1 protein level ratio 1e-275 rs11767557 1 GCST90313542 no MR -> candidate analysis
EPHA1/LTBR protein level ratio 5e-248 rs11767557 1 GCST90314676 no MR -> candidate analysis
EPHA1 protein levels 3e-229 rs75045569 3 GCST90469129 no MR -> candidate analysis
Blood protein levels 2e-223 rs4725617 1 GCST006585 no MR -> candidate analysis
Ephrin type-A receptor 1 levels (EPHA1.3431.54.2) 9e-83 rs4421280 1 GCST90241065 no MR -> candidate analysis
Ephrin type-A receptor 1 level in Chronic kidney disease wit 1e-61 rs4725617 1 GCST90237377 no MR -> candidate analysis
Serum levels of protein EPHA1 2e-60 rs11767557 1 GCST90088381 no MR -> candidate analysis
Gamma glutamyltransferase levels (UKB data field 30730) 4e-28 rs34372369 2 GCST90468070 no MR -> candidate analysis
Liver enzyme levels (gamma-glutamyl transferase) 4e-27 rs34372369 1 GCST90013407 no MR -> candidate analysis
Gamma glutamyl transferase levels 6e-27 rs34372369 2 GCST90428730 no MR -> candidate analysis
Height 4e-26 rs34372369 1 GCST90245848 MR: beta=0.0083, p=0.16 (cis)
…and 51 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 409 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Alzheimer disease 0.824 common-variant locus no MR -> candidate analysis
pathological myopia 0.394 common-variant locus no MR -> candidate analysis
late-onset Alzheimers disease 0.379 common-variant locus no MR -> candidate analysis
response to xenobiotic stimulus 0.25 common-variant locus no MR -> candidate analysis
bladder exstrophy 0.195 established (curated) no MR -> candidate analysis

Of the 5 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Ephrin type-A receptor 1)
gnomAD constraint pLI=3e-26, LOEUF=0.994 — LoF-tolerant
GWAS Catalog 54 unique SNPs / 108 rows
ClinVar 267 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance